QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
11.55
-0.54 (-4.47%)
Nov 10, 2026, 4:00 PM EST - Market closed
QuidelOrtho Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Revenue Revenue Growth | 2,593 | 2,730 | 2,783 | 2,998 | 3,266 | 1,699 |
Revenue Growth | -4.46% | -1.89% | -7.17% | -8.21% | 92.28% | 2.22% |
Gross Profit Gross Profit Growth | 1,154 | 1,278 | 1,287 | 1,497 | 1,936 | 1,278 |
Operating Income Operating Income Growth | 4.5 | 123.6 | 47 | 257 | 994.8 | 915.6 |
Net Income Net Income Growth | -369.2 | -1,132 | -2,052 | -10.1 | 548.7 | 704.2 |
Earnings Per Share EPS Growth | -5.40 | -16.69 | -30.54 | -0.15 | 9.56 | 16.43 |
EPS Growth | - | - | - | - | -41.81% | -11.64% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Labs Labs Growth | 1,478 | 1,506 | 1,427 | 1,425 | 820.2 | 44.8 |
Immunohematology Immunohematology Growth | 555.5 | 543.8 | 522 | 512.4 | 296.8 | - |
Donor Screening Donor Screening Growth | 25.3 | 52.6 | 115.1 | 136.1 | 97 | - |
Point of Care Point of Care Growth | 513.7 | 601.6 | 694.6 | 892.2 | 1,955 | 1,453 |
Molecular Diagnostics Molecular Diagnostics Growth | 20.3 | 26.5 | 24 | 31.7 | 96.7 | 200.5 |
Revenue (Total) Revenue (Total) Growth | 2,593 | 2,730 | 2,783 | 2,998 | 3,266 | 1,699 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Cash & Investments Cash & Investments Growth | 166.4 | 170.1 | 99.6 | 174.9 | 381.9 | 866.4 |
Total Debt Total Debt Growth | 3,116 | 2,854 | 2,681 | 2,621 | 2,851 | 139.3 |
Net Cash (Debt) Net Cash Growth | -2,950 | -2,684 | -2,582 | -2,446 | -2,469 | 727.1 |
Net Cash Growth | - | - | - | - | - | 90.62% |
Net Cash Per Share Net Cash Per Share Growth | -43.17 | -39.58 | -38.42 | -36.62 | -43.02 | 16.95 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 7.9 | 105.2 | 83 | 280.2 | 885.3 | 805.9 |
Capital Expenditures CapEx Growth | -125 | -188.2 | -195.1 | -209.3 | -140.9 | -292.8 |
Free Cash Flow Free Cash Flow Growth | -117.1 | -83 | -112.1 | 70.9 | 744.4 | 513.1 |
Free Cash Flow Growth | - | - | - | -90.48% | 45.08% | -9.15% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 27, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
Gross Margin | 44.51% | 46.81% | 46.23% | 49.94% | 59.28% | 75.26% |
Operating Margin | 0.17% | 4.53% | 1.69% | 8.57% | 30.46% | 53.90% |
Pretax Margin | -12.96% | -40.57% | -76.59% | -0.97% | 22.53% | 53.00% |
Profit Margin | -14.24% | -41.45% | -73.74% | -0.34% | 16.80% | 41.46% |
FCF Margin | -4.52% | -3.04% | -4.03% | 2.37% | 22.79% | 30.21% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 28, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 2, 2022 |
PE Ratio | - | - | - | - | 10.31 | 7.99 |
Forward PE | 11.24 | 13.89 | 21.58 | 14.60 | 17.67 | 14.83 |
P/FCF Ratio | - | - | - | 69.46 | 7.60 | 10.96 |
PS Ratio | 0.30 | 0.73 | 1.07 | 1.64 | 1.73 | 3.31 |